Where Next For Present Stem Cell Therapies?
First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated pa...
Search fresh public links, source activity, and ready-to-use post angles for Emerging Therapy.
Fresh curated links around Emerging Therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
First generation stem cell therapies have become widespread; they are readily accessed in medical tourism clinics, and are also available for a range of issues in more regulated pa...
Rather than deplete malfunctioning B cells as many other emerging autoimmune drugs do, Ai3Bio’s therapies are designed to eliminate a particular group of T helper cells.
Mumbai (Maharashtra) [India], September 2: A blood cancer diagnosis is abrupt and overwhelming. When families hear terms like Acute Myeloid Leukemia or Hodgkin Lymphoma, finding ge...
Data from an early trial showed the company’s “gamma delta” cell therapy surpassed benchmarks set by personalized CAR-T treatments tested in lupus.
In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...
Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...
Most people have heard of cancer immunotherapy by now. These treatments help a patient’s own immune system recognize and attack cancer. The best-known examples are immune checkpoin...
RCT’s focused-energy approach delivers therapeutic results in 3-5 sessions, now available at the Center for New Medicine in…
Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeuti...
Cell and gene therapy is accelerating across Asia-Pacific, but manufacturing remains fragmented. Strategic automation, adaptable bioprocessing platforms, stronger supply chains, an...
Company Making Critical Progress in Scalable Manufacturing and Preparing the Lead Trispecific Candidate for Future Human TestingTrispecifics Combine Three Complementary Cancer-Figh...
Mumbai (Maharashtra) [India], October 12: For much of the past two decades, immunotherapy was thought of as a treatment held in reserve — an option to try after chemotherapy and ra...
One analyst views Roivant’s pulmonary hypertension drug as a future $10 billion-plus seller. Elsewhere, AstraZeneca overcame a negative advisory committee vote and Pharvaris claime...
Electra Therapeutics’ IPO cash will support a potential first-in-class drug whose lead indication is a rare hyperinflammatory disorder with no FDA-approved treatments. Meanwhile, c...
The world of skin rejuvenation has changed dramatically in just the last few […]
Over the past decade, a succession of new GvHD treatments targeting different components of the immune response have been approved. The post New Graft-versus-Host Disease treatment...
A range of gene therapies are presently available in the medical tourism community of clinics outside the US and Europe, largely originating with a small number of companies such a...
The concept of targeted therapeutics is often traced back to German Nobel laureate Paul Ehrlich’s “magic bullet” in 1907, which envisioned a single entity that could both recognize...
The first human application of partial epigenetic reprogramming of aged tissues, using adeno-associated viral (AAV) vectors, was not in fact the first patient dosed in the recently...
A branch of the European Medicines Agency (EMA) has recommended that the experimental therapy denecimig be approved to treat adults and children with hemophilia A, with or without...
New types of bispecifics, antibody-drug conjugates and cell therapies haven’t yet proven themselves in the clinic. Pharmaceutical companies are betting billions anyway.
This proceedings eBook, developed in partnership with GEN and Cincinnati Children’s Hospital Applied Gene and Cell Therapy Center, captures perspectives and lessons from The Cell S...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.